Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Magenta Elevate™ Clinical Feasibility Study in Cardiogenic Shock

NCT: NCT07293923 · RECRUITING

NCT IDNCT07293923
StatusRECRUITING
Start Date2025-11-05
Completion2028-02-28
SponsorMagenta Medical Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The Elevate™ CS Clinical Feasibility Study is designed to evaluate the initial safety, effectiveness, and device performance of the Magenta Elevate™ System in patients with cardiogenic shock due to isolated or predominant left ventricular failure.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑